News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,331 Results
Type
Article (2447)
Company Profile (39)
Press Release (35845)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14158)
Career Advice (77)
Deals (2086)
Drug Delivery (9)
Drug Development (4107)
Employer Resources (10)
FDA (431)
Job Trends (773)
News (20185)
Policy (1054)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (145)
Allergies (6)
Alliances (3489)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (15)
Approvals (432)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (485)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (143)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (44)
Cervical cancer (2)
Clinical research (3184)
Collaboration (95)
Compensation (48)
COVID-19 (181)
CRISPR (7)
C-suite (30)
Cystic fibrosis (2)
Data (116)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (468)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4259)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6046)
Executive appointments (97)
FDA (478)
Featured Employer (3)
Funding (79)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (707)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (186)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (991)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1167)
Metabolic disorders (34)
Multiple sclerosis (8)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (92)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (367)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5668)
Pharmaceutical (5)
Phase I (1377)
Phase II (1597)
Phase III (848)
Pipeline (77)
Policy (12)
Postmarket research (30)
Preclinical (594)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (421)
Recruiting (5)
Regulatory (806)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (359)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1763)
Vaccines (29)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (14)
Last 7 days (47)
Last 30 days (229)
Last 365 days (2555)
2025 (793)
2024 (2630)
2023 (2888)
2022 (3772)
2021 (4054)
2020 (3476)
2019 (2062)
2018 (1554)
2017 (1796)
2016 (1625)
2015 (1833)
2014 (1370)
2013 (1192)
2012 (1399)
2011 (1333)
2010 (1182)
Location
Africa (43)
Alabama (2)
Arizona (15)
Asia (1872)
Australia (299)
California (846)
Canada (135)
China (38)
Colorado (20)
Connecticut (11)
Delaware (4)
Europe (3872)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (310)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (91)
Northern California (367)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (50)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (359)
Tennessee (2)
Texas (72)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (52)
Wisconsin (6)
38,331 Results for "olink bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology
January 27, 2025
·
3 min read
Business
Olink reports first quarter 2024 financial results
Olink Holding AB announced its unaudited financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Olink Holding AB announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research.
June 6, 2024
·
5 min read
Business
Olink publishes 2023 annual report
Olink Holding AB announced that the Annual Report for 2023 is now available on the Company’s website.
March 25, 2024
·
1 min read
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
Olink Holding AB reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood that may provide a 7-year warning for various cancers.
May 30, 2024
·
5 min read
Olink announces change of date for Annual General Meeting - March 08, 2024
Olink Holding AB, announced that Olink’s 2024 Annual General Meeting will be held in Uppsala, Sweden on April 19th, 2024.
March 8, 2024
·
1 min read
Press Releases
Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study
January 10, 2025
·
4 min read
Business
Olink reports fourth quarter and full year 2023 financial results
Olink Holding AB announced its unaudited financial results for the fourth quarter ended December 31, 2023.
March 25, 2024
·
17 min read
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
Olink Holding AB announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases.
April 2, 2024
·
5 min read
Business
Olink reports third quarter 2023 financial results
Olink Holding AB announced its unaudited financial results for the third quarter ended September 30, 2023.
November 15, 2023
·
15 min read
1 of 3,834
Next
